142 related articles for article (PubMed ID: 31499155)
21. Molluscum contagiosum in pediatric patients: to treat or not to treat? Could a personalized imiquimod regimen be the answer to the dilemma?
Gualdi G; Pascalucci C; Panarese F; Prignano F; Giuliani F; Verga E; Amerio P; Verdolini R
J Dermatolog Treat; 2022 Feb; 33(1):443-448. PubMed ID: 32347136
[TBL] [Abstract][Full Text] [Related]
22. Cosmetic Effects of Ingenol Mebutate Gel in the Treatment of Field-Cancerized Photodamaged Skin.
Braun SA; Gerber PA
Dermatol Surg; 2015 Nov; 41(11):1328-9. PubMed ID: 26448312
[No Abstract] [Full Text] [Related]
23. Treatment of Imiquimod Resistant Epidermodysplasia Verruciformis With Ingenol Mebutate.
Kim C; Hashemi P; Caglia M; Shulman K
J Drugs Dermatol; 2016 Mar; 15(3):350-2. PubMed ID: 26954321
[TBL] [Abstract][Full Text] [Related]
24. Topical Imiquimod is an Effective and Safe Drug for Molluscum Contagiosum in Children.
Badavanis G; Pasmatzi E; Monastirli A; Georgiou S; Tsambaos D
Acta Dermatovenerol Croat; 2017 Jul; 25(2):164-166. PubMed ID: 28871935
[TBL] [Abstract][Full Text] [Related]
25. Pemphigus-like eruption as a complication of molluscum contagiosum treatment with imiquimod in a 5-year-old girl.
Zhong CS; Hasbun MT; Jones KM; Schmidt BAR; Hussain SH
Pediatr Dermatol; 2020 Mar; 37(2):379-380. PubMed ID: 32027759
[TBL] [Abstract][Full Text] [Related]
26. Combination topical treatment of molluscum contagiosum with cantharidin and imiquimod 5% in children: a case series of 16 patients.
Ross GL; Orchard DC
Australas J Dermatol; 2004 May; 45(2):100-2. PubMed ID: 15068455
[TBL] [Abstract][Full Text] [Related]
27. Imiquimod: a new immune response modifier for the treatment of external genital warts and other diseases in dermatology.
Berman B
Int J Dermatol; 2002 May; 41 Suppl 1():7-11. PubMed ID: 12087816
[No Abstract] [Full Text] [Related]
28. Quality of life and side effects in patients with actinic keratosis treated with ingenol mebutate: a pilot study.
Jubert-Esteve E; Del Pozo-Hernando LJ; Izquierdo-Herce N; Bauzá-Alonso A; Martín-Santiago A; Jones-Caballero M
Actas Dermosifiliogr; 2015 Oct; 106(8):644-50. PubMed ID: 26130156
[TBL] [Abstract][Full Text] [Related]
29. Recalcitrant molluscum contagiosum in an HIV-afflicted male treated successfully with topical imiquimod.
Brown CW; O'Donoghue M; Moore J; Tharp M
Cutis; 2000 Jun; 65(6):363-6. PubMed ID: 10879304
[TBL] [Abstract][Full Text] [Related]
30. Treatment of multiple giant molluscum contagiosum in a renal transplant patient with imiquimod 5% cream.
Gardner LS; Ormond PJ
Clin Exp Dermatol; 2006 May; 31(3):452-3. PubMed ID: 16681599
[No Abstract] [Full Text] [Related]
31. Pharmacokinetics of ingenol mebutate gel under maximum use conditions in large treatment areas.
Bucko AD; Jarratt M; Stough DB; Kyhl L; Villumsen J; Hall A
J Dermatolog Treat; 2018 Feb; 29(1):74-79. PubMed ID: 28524709
[TBL] [Abstract][Full Text] [Related]
32. Comparative study of 5 % potassium hydroxide solution versus 0.05% tretinoin cream for Molluscum Contagiosum in children.
Rajouria EA; Amatya A; Karn D
Kathmandu Univ Med J (KUMJ); 2011; 9(36):291-4. PubMed ID: 22710541
[TBL] [Abstract][Full Text] [Related]
33. PEP005 (ingenol mebutate) gel, a novel agent for the treatment of actinic keratosis: results of a randomized, double-blind, vehicle-controlled, multicentre, phase IIa study.
Siller G; Gebauer K; Welburn P; Katsamas J; Ogbourne SM
Australas J Dermatol; 2009 Feb; 50(1):16-22. PubMed ID: 19178487
[TBL] [Abstract][Full Text] [Related]
34. 2020 European guideline on the management of genital molluscum contagiosum.
Edwards S; Boffa MJ; Janier M; Calzavara-Pinton P; Rovati C; Salavastru CM; Rongioletti F; Wollenberg A; Butacu AI; Skerlev M; Tiplica GS
J Eur Acad Dermatol Venereol; 2021 Jan; 35(1):17-26. PubMed ID: 32881110
[TBL] [Abstract][Full Text] [Related]
35. Unethical use of imiquimod as a comparator group in a randomized clinical trial of children with molluscum contagiosum.
Katz KA
J Am Acad Dermatol; 2021 Feb; 84(2):e113. PubMed ID: 33058946
[No Abstract] [Full Text] [Related]
36. Topical treatment of molluscum contagiosum with imiquimod 5% cream in Turkish children.
Arican O
Pediatr Int; 2006 Aug; 48(4):403-5. PubMed ID: 16911087
[TBL] [Abstract][Full Text] [Related]
37. The European Medicines Agency approval of ingenol mebutate (Picato) for the cutaneous treatment of non-hyperkeratotic, non-hypertrophic actinic keratosis in adults: summary of the scientific assessment of the Committee for Medicinal Products for Human Use (CHMP).
Tzogani K; Nagercoil N; Hemmings RJ; Samir B; Gardette J; Demolis P; Salmonson T; Pignatti F
Eur J Dermatol; 2014; 24(4):457-63. PubMed ID: 25115145
[TBL] [Abstract][Full Text] [Related]
38. Assessment of Efficacy and Irritation of Ingenol Mebutate Gel 0.015% Used With or Without Dimethicone Lotion for Treatment of Actinic Keratosis on the Face.
Jim On SC; Hashim PW; Nia JK; Lebwohl MG
J Drugs Dermatol; 2017 May; 16(5):432-436. PubMed ID: 28628678
[TBL] [Abstract][Full Text] [Related]
39. Imiquimod therapy for molluscum contagiosum.
Liota E; Smith KJ; Buckley R; Menon P; Skelton H
J Cutan Med Surg; 2000 Apr; 4(2):76-82. PubMed ID: 11179929
[TBL] [Abstract][Full Text] [Related]
40. Treatment of molluscum contagiosum with silver nitrate paste.
Niizeki K; Hashimoto K
Pediatr Dermatol; 1999; 16(5):395-7. PubMed ID: 10571843
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
